Trial of RAD001 in Triple Negative Metastatic Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: RAD 001
Sponsor: Milton S. Hershey Medical Center
Collaborators: Novartis